Duke's Gastrointestinal Oncology Program combines the expertise of world-class patient treatment teams with exciting advances in research for patients battling cancers of the esophagus, stomach, pancreas, liver, biliary system, small intestine, colon, and rectum, including uncommon tumors such as carcinoids and neuroendocrine tumors, and gastrointestinal stromal tumors.

Patients from around the world choose the individualized care offered by Duke for its state-of-the-art treatments.

As one of the world’s premier academic medical centers, Duke has the resources and expertise to provide patients with the full scope of diagnostic and treatment options, including the most innovative therapies in the world. We provide comprehensive, compassionate care for patients fighting cancer.

Always, our aim is to ensure that each individual’s quality of life remains as high as possible throughout treatment and recovery.